Report Detail
Global Anticancer Drugs Market Insights and Forecast to 2026
- RnM4133481 |
- 13 August, 2020 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
Anticancer Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anticancer Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Anticancer Drugs market is segmented into
Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)
Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)
Hormonal Drugs
Segment by Application, the Anticancer Drugs market is segmented into
Lung Cancer
Breast Cancer
Leukemia
Colorectal Cancer
Regional and Country-level Analysis
The Anticancer Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Anticancer Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Anticancer Drugs Market Share Analysis
Anticancer Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anticancer Drugs business, the date to enter into the Anticancer Drugs market, Anticancer Drugs product introduction, recent developments, etc.
The major vendors covered:
F. Hoffmann-La Roche Ltd
Eli Lilly and Company
CELGENE CORPORATION
Novartis AG
Pfizer Inc
Amgen Inc
Bayer AG
AstraZeneca
Takeda Pharmaceutical Company Limited
Merck & Co.
1 Study Coverage
- 1.1 Anticancer Drugs Product Introduction
- 1.2 Market Segments
- 1.3 Key Anticancer Drugs Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Anticancer Drugs Market Size Growth Rate by Type
- 1.4.2 Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)
- 1.4.3 Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)
- 1.4.4 Hormonal Drugs
- 1.5 Market by Application
- 1.5.1 Global Anticancer Drugs Market Size Growth Rate by Application
- 1.5.2 Lung Cancer
- 1.5.3 Breast Cancer
- 1.5.4 Leukemia
- 1.5.5 Colorectal Cancer
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Anticancer Drugs Market Size, Estimates and Forecasts
- 2.1.1 Global Anticancer Drugs Revenue 2015-2026
- 2.1.2 Global Anticancer Drugs Sales 2015-2026
- 2.2 Global Anticancer Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Anticancer Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Anticancer Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Anticancer Drugs Competitor Landscape by Players
- 3.1 Anticancer Drugs Sales by Manufacturers
- 3.1.1 Anticancer Drugs Sales by Manufacturers (2015-2020)
- 3.1.2 Anticancer Drugs Sales Market Share by Manufacturers (2015-2020)
- 3.2 Anticancer Drugs Revenue by Manufacturers
- 3.2.1 Anticancer Drugs Revenue by Manufacturers (2015-2020)
- 3.2.2 Anticancer Drugs Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Anticancer Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Anticancer Drugs Revenue in 2019
- 3.2.5 Global Anticancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Anticancer Drugs Price by Manufacturers
- 3.4 Anticancer Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Anticancer Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Anticancer Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Anticancer Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Anticancer Drugs Market Size by Type (2015-2020)
- 4.1.1 Global Anticancer Drugs Sales by Type (2015-2020)
- 4.1.2 Global Anticancer Drugs Revenue by Type (2015-2020)
- 4.1.3 Anticancer Drugs Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Anticancer Drugs Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Anticancer Drugs Sales Forecast by Type (2021-2026)
- 4.2.2 Global Anticancer Drugs Revenue Forecast by Type (2021-2026)
- 4.2.3 Anticancer Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Anticancer Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Anticancer Drugs Market Size by Application (2015-2020)
- 5.1.1 Global Anticancer Drugs Sales by Application (2015-2020)
- 5.1.2 Global Anticancer Drugs Revenue by Application (2015-2020)
- 5.1.3 Anticancer Drugs Price by Application (2015-2020)
- 5.2 Anticancer Drugs Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Anticancer Drugs Sales Forecast by Application (2021-2026)
- 5.2.2 Global Anticancer Drugs Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Anticancer Drugs Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Anticancer Drugs by Country
- 6.1.1 North America Anticancer Drugs Sales by Country
- 6.1.2 North America Anticancer Drugs Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Anticancer Drugs Market Facts & Figures by Type
- 6.3 North America Anticancer Drugs Market Facts & Figures by Application
7 Europe
- 7.1 Europe Anticancer Drugs by Country
- 7.1.1 Europe Anticancer Drugs Sales by Country
- 7.1.2 Europe Anticancer Drugs Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Anticancer Drugs Market Facts & Figures by Type
- 7.3 Europe Anticancer Drugs Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Anticancer Drugs by Region
- 8.1.1 Asia Pacific Anticancer Drugs Sales by Region
- 8.1.2 Asia Pacific Anticancer Drugs Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Anticancer Drugs Market Facts & Figures by Type
- 8.3 Asia Pacific Anticancer Drugs Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Anticancer Drugs by Country
- 9.1.1 Latin America Anticancer Drugs Sales by Country
- 9.1.2 Latin America Anticancer Drugs Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Anticancer Drugs Market Facts & Figures by Type
- 9.3 Central & South America Anticancer Drugs Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Anticancer Drugs by Country
- 10.1.1 Middle East and Africa Anticancer Drugs Sales by Country
- 10.1.2 Middle East and Africa Anticancer Drugs Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Anticancer Drugs Market Facts & Figures by Type
- 10.3 Middle East and Africa Anticancer Drugs Market Facts & Figures by Application
11 Company Profiles
- 11.1 F. Hoffmann-La Roche Ltd
- 11.1.1 F. Hoffmann-La Roche Ltd Corporation Information
- 11.1.2 F. Hoffmann-La Roche Ltd Description and Business Overview
- 11.1.3 F. Hoffmann-La Roche Ltd Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 F. Hoffmann-La Roche Ltd Anticancer Drugs Products Offered
- 11.1.5 F. Hoffmann-La Roche Ltd Related Developments
- 11.2 Eli Lilly and Company
- 11.2.1 Eli Lilly and Company Corporation Information
- 11.2.2 Eli Lilly and Company Description and Business Overview
- 11.2.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Eli Lilly and Company Anticancer Drugs Products Offered
- 11.2.5 Eli Lilly and Company Related Developments
- 11.3 CELGENE CORPORATION
- 11.3.1 CELGENE CORPORATION Corporation Information
- 11.3.2 CELGENE CORPORATION Description and Business Overview
- 11.3.3 CELGENE CORPORATION Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 CELGENE CORPORATION Anticancer Drugs Products Offered
- 11.3.5 CELGENE CORPORATION Related Developments
- 11.4 Novartis AG
- 11.4.1 Novartis AG Corporation Information
- 11.4.2 Novartis AG Description and Business Overview
- 11.4.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Novartis AG Anticancer Drugs Products Offered
- 11.4.5 Novartis AG Related Developments
- 11.5 Pfizer Inc
- 11.5.1 Pfizer Inc Corporation Information
- 11.5.2 Pfizer Inc Description and Business Overview
- 11.5.3 Pfizer Inc Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Pfizer Inc Anticancer Drugs Products Offered
- 11.5.5 Pfizer Inc Related Developments
- 11.6 Amgen Inc
- 11.6.1 Amgen Inc Corporation Information
- 11.6.2 Amgen Inc Description and Business Overview
- 11.6.3 Amgen Inc Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Amgen Inc Anticancer Drugs Products Offered
- 11.6.5 Amgen Inc Related Developments
- 11.7 Bayer AG
- 11.7.1 Bayer AG Corporation Information
- 11.7.2 Bayer AG Description and Business Overview
- 11.7.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Bayer AG Anticancer Drugs Products Offered
- 11.7.5 Bayer AG Related Developments
- 11.8 AstraZeneca
- 11.8.1 AstraZeneca Corporation Information
- 11.8.2 AstraZeneca Description and Business Overview
- 11.8.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 AstraZeneca Anticancer Drugs Products Offered
- 11.8.5 AstraZeneca Related Developments
- 11.9 Takeda Pharmaceutical Company Limited
- 11.9.1 Takeda Pharmaceutical Company Limited Corporation Information
- 11.9.2 Takeda Pharmaceutical Company Limited Description and Business Overview
- 11.9.3 Takeda Pharmaceutical Company Limited Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Takeda Pharmaceutical Company Limited Anticancer Drugs Products Offered
- 11.9.5 Takeda Pharmaceutical Company Limited Related Developments
- 11.10 Merck & Co.
- 11.10.1 Merck & Co. Corporation Information
- 11.10.2 Merck & Co. Description and Business Overview
- 11.10.3 Merck & Co. Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Merck & Co. Anticancer Drugs Products Offered
- 11.10.5 Merck & Co. Related Developments
- 11.1 F. Hoffmann-La Roche Ltd
- 11.1.1 F. Hoffmann-La Roche Ltd Corporation Information
- 11.1.2 F. Hoffmann-La Roche Ltd Description and Business Overview
- 11.1.3 F. Hoffmann-La Roche Ltd Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 F. Hoffmann-La Roche Ltd Anticancer Drugs Products Offered
- 11.1.5 F. Hoffmann-La Roche Ltd Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Anticancer Drugs Market Estimates and Projections by Region
- 12.1.1 Global Anticancer Drugs Sales Forecast by Regions 2021-2026
- 12.1.2 Global Anticancer Drugs Revenue Forecast by Regions 2021-2026
- 12.2 North America Anticancer Drugs Market Size Forecast (2021-2026)
- 12.2.1 North America: Anticancer Drugs Sales Forecast (2021-2026)
- 12.2.2 North America: Anticancer Drugs Revenue Forecast (2021-2026)
- 12.2.3 North America: Anticancer Drugs Market Size Forecast by Country (2021-2026)
- 12.3 Europe Anticancer Drugs Market Size Forecast (2021-2026)
- 12.3.1 Europe: Anticancer Drugs Sales Forecast (2021-2026)
- 12.3.2 Europe: Anticancer Drugs Revenue Forecast (2021-2026)
- 12.3.3 Europe: Anticancer Drugs Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Anticancer Drugs Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Anticancer Drugs Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Anticancer Drugs Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Anticancer Drugs Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Anticancer Drugs Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Anticancer Drugs Sales Forecast (2021-2026)
- 12.5.2 Latin America: Anticancer Drugs Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Anticancer Drugs Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Anticancer Drugs Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Anticancer Drugs Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Anticancer Drugs Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Anticancer Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Anticancer Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Anticancer Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Anticancer Drugs. Industry analysis & Market Report on Anticancer Drugs is a syndicated market report, published as Global Anticancer Drugs Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Anticancer Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
